Jim Scopa
Jim Scopa previously was a Partner and Co-Director of Healthcare Investment Banking at Thomas Weisel Partners. Mr. Scopa also served on the Investment Committee for Thomas Weisel Partners Health Care venture fund. Prior to joining TWP in 2002, he was a Managing Director and Global
Co-Head of Healthcare Investment Banking at Deutsche Banc Alex. Brown. Mr. Scopa has over 18 years of experience in healthcare investment banking, specializing in financings and M&A for healthcare companies. He has been the senior banker on numerous public offerings for life sciences companies
including MPM portfolio companies CoTherix, Inc. (NASDAQ:CTRX), Metabasis Therapeutics, Inc. (NASDAQ:MBRX), and Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). Mr. Scopa joined MPM’s San Francisco office in May 2005. He received an A.B. from Harvard College (Phi Beta Kappa), an M.B.A. from Harvard
Business School and a J.D. from Harvard Law School. |
jscopa@mpmcapital.com |
